Zytomil Coated Tablet
PDF Leaflet Revision Date: 20 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive episodes and anxiety disorders.
Dosage (summary)
Adults: 10 mg daily, max 20 mg; Panic disorder: 5 mg for 1 week, then 10 mg daily, max 20 mg.
Onset of Action / Duration
Onset: 2-4 weeks, Duration: several months.
Special Populations
- Elderly patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- MAO inhibitors
- Pimozide
- Linezolid
- QT prolonging medications
Contraindications
- Hypersensitivity to escitalopram
- Children under 18 years
- QT interval prolongation
- Porphyria
Common side effects
- Nausea
- Dizziness
- Insomnia
- Sexual dysfunction
Counselling Points
- Monitor for worsening depression or suicidality.
- Avoid abrupt discontinuation.
- Caution with alcohol and CNS depressants.
Serious warnings
- Suicidality risk
- QT interval prolongation
- Withdrawal symptoms
Important Disclaimer
The Zytomil Coated Tablet professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
